OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
S1801 (Neoadjuvant Pembro In Melanoma)
10 minutes
Posted Mar 9, 2023 at 9:00 pm.
0:00
10:54
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
We review a clever study looking at neoadjvuant & adjuvant pembrolizumab vs. only adjuvant pembrolizumab in melanoma.
Link: 10.1056/NEJMoa2211437
We also discuss some updates on abemaciclib and osimertinib
Previous
DA-EPOCH (R)
Next
Chemo-Induced Ovarian Dysfunction
← See all 273 episodes of OncoPharm